FIELD: medicine, immunology, immunotherapy, oncology. SUBSTANCE: method involves the use of papilloma virus antigen taken among the following group of antigens: HPV16 E6, HPV16 E7, HPV18 E6, HPV18 E7, HPV6 E4, HPV6 L1, HPV11 E4 and HPV11 L1. Except for antigen, the composition can comprise stabilizing detergent, micelle-forming agent, biodegradable and biocompatible oil. Composition is used for treatment of cervical cancer, pointed condyloma. The use of composition ensure to enhance immune response for antigen of papilloma virus. EFFECT: enhanced effectiveness of composition, valuable antitumor properties. 8 cl, 19 dwg, 6 tbl, 11 ex
| Title |
Year |
Author |
Number |
| ANTIGENIC COMPOSITION FOR INDUCING CYTOTOXIC T-LYMPHOCYTES RESPONSE, METHOD OF INDUCTION AND METHOD OF PATIENTS TREATMENT |
1992 |
- Sejmal Rejchaurdkhuri
- Vil'Jam Kh.Rastetter
|
RU2129439C1 |
| SYNERGETIC COMPOSITION AND METHODS FOR TREATMENT OF STATES OF NEOPLASTIC OR MALIGNANT GROWTH AND RECOVERY OR ENHANCEMENT OF HEMOPOIESIS |
1998 |
- Khanna Nehbil
- Braslavskij Gehri R.
- Kharikharan Kandasami
|
RU2219947C2 |
| RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMA VIRUS EPITOPES, PROTEIN EMBEDDED ADENYLATECYCLASE OR ITS FRAGMENT, ITS THERAPEUTIC APPLICATION |
2005 |
- Preville Khav'Er-Ehdmond-Ehduard
- Leklerk Klod
- Ladant Daniel
- Timmerman Benedikt
|
RU2441022C2 |
| STABLE VECTOR OF CONSTITUTIVELY HIGH EXPRESSION FOR OBTAINING HPV VACCINE, AND RECOMBINANT LACTIC ACID BACTERIA TRANSFORMED BY THIS VECTOR |
2010 |
- Sjung Moon-Khi
- Poo Kharuong
- Li Il' Khan
|
RU2492240C2 |
| VACCINE COMPOSITION SHOWING PROPERTY TO CAUSE CYTOLYTIC T-CELLULAR RESPONSE IN MAMMALS, METHOD OF PREPARING CYTOLYTIC T-CELLULAR RESPONSE IN VITRO, METHOD OF VACCINE PREPARING |
1993 |
- Zhan-Pol' Priel'
- Natali Mari-Zhozef Klod Garkon-Zhonson
- Monsef Slaui
- P'Etro Pala
|
RU2118164C1 |
| COMPOSITIONS CAUSING SPECIFIC RESPONSE OF CYTOTOXIC T-LYMPHOCYTES, INCLUDING LYMPH-ABLATIVE COMPOUND AND MOLECULE WHICH CONTAINS ANTIGEN SEQUENCES AND IS TARGETED AT SPECIALISED ANTIGEN-PRESENTING CELLS |
2007 |
- Previll' Ksav'E
- Timmerman Benedikt
|
RU2448729C2 |
| COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION |
2014 |
- Isii Ken
- Kobiyama Koudzi
- Aosi Taiki
- Takesita Fumikhiko
- Kasuya Yudzi
- Niva Takako
- Koizumi Makoto
|
RU2723943C2 |
| ENHANCING IMMUNE RESPONSE AND TARGET FOCUS BY ANTIGENS AND/OR DRUG |
2008 |
|
RU2548685C2 |
| VECTORS FOR DELIVERY OF MOLECULES TO CD11b-EXPRESSING CELLS |
2001 |
- Leklerk Klod
- Germonpre P'Er
- Ladan Daniel'
- Gjuizo Nikol'
- Kelef Nadija
- Bosh Sesil'
- Fajoll' Katrin
- Ehl'-Azami Ehl'-Idrissi Mokhammed
|
RU2312143C2 |
| RECOMBINANT PROTEIN COMPOSITION, METHOD FOR PREPARING SUCH COMPOSITION, PHARMACEUTICAL KIT OF REAGENTS FOR IMMUNOTHERAPY AND PROPHYLACTIC VACCINATION OF TUMOR DISEASES IN ANUS-GENITAL SPHERE, METHOD FOR IMMUNOTHERAPY AND PROPHYLACTIC VACCINATION BASED ON THEREOF |
2002 |
- Pal'Tsev M.A.
- Severin E.S.
- Kiselev O.I.
- Kiselev V.I.
- Sveshnikov P.G.
|
RU2229307C1 |
